Medroute Pharmaceuticals Private Limited, a active private limited company, was established on 22 August 2014 in Hoshiarpur, Punjab, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U74900PB2014PTC038855. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Formerly known as Med Route India Private Limited. It upholds a compliant status. Its leadership includes Varun Jain (Director), Rita Jain (Director), Sneha Jain (Director). Past directors included Nitin Jain. It holds ₹6.70 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Medroute Pharmaceuticals Private Limited Opp. Pnb Bank,Una Road, Hoshiarpur, Punjab, 146001.
U74900PB2014PTC038855
038855
22 August 2014
₹1.00 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Medroute Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varun Jain | Director | 22 Aug 2014 | Current |
| Rita Jain | Director | 22 Aug 2014 | Current |
| Sneha Jain | Director | 22 Aug 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Oct 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medroute Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 11.79% decrease. The company also saw a substantial fall in profitability, with a 76.81% decrease in profit. The company's net worth dipped by a decrease of 8.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medroute Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹67,005,615.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2025 | Hdfc Bank Limited | ₹5.00 M | Open |
| 06 Sep 2024 | Axis Bank Limited | ₹4.90 Cr | Open |
| 30 Jan 2024 | Others | ₹6.00 M | Open |
| 11 Nov 2022 | Hdfc Bank Limited | ₹7.01 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medroute Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medroute Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medroute Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 5.00 M with Charge ID 101098646 was registered on 30 Apr 2025. was recorded as a recent event.
Progress on Medroute Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Axis Bank Limited amounted to Rs. 49.00 M with Charge ID 100986170 was registered on 06 Sep 2024. was recorded as a recent event.
Medroute Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
A charge with Others amounted to Rs. 6.00 M with Charge ID 100932442 was registered on 30 Jan 2024. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 7.01 M with Charge ID 100665490 was registered on 11 Nov 2022. was documented.
The CIN of Medroute Pharmaceuticals Private Limited is U74900PB2014PTC038855.
Medroute Pharmaceuticals Private Limited is headquartered at Medroute Pharmaceuticals Private Limited Opp. Pnb Bank,Una Road, Hoshiarpur, Punjab, 146001.
Medroute Pharmaceuticals Private Limited was incorporated on 22 August 2014.
The current directors of Medroute Pharmaceuticals Private Limited are
The primary industry of Medroute Pharmaceuticals Private Limited is Manufacturing.
Medroute Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medroute Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Medroute Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX